Medical Marijuana (Medical Marijuana) Debt-to-Revenue : 0.56 (As of Dec. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Medical Marijuana Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Medical Marijuana's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was $1.41 Mil. Medical Marijuana's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was $13.43 Mil. Medical Marijuana's annualized Revenue for the quarter that ended in Dec. 2017 was $26.52 Mil. Medical Marijuana's annualized Debt-to-Revenue for the quarter that ended in Dec. 2017 was 0.56.

Medical Marijuana Debt-to-Revenue Historical Data

The historical data trend for Medical Marijuana's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Marijuana Debt-to-Revenue Chart

Medical Marijuana Annual Data

Trend

Dec09

Dec10

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Debt-to-Revenue

Get a 7-Day Free Trial

0.27

1.83

1.47

0.56

Medical Marijuana Semi-Annual Data
	Dec09	Dec10	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Debt-to-Revenue	Get a 7-Day Free Trial			0.27	1.83	-	1.47	0.56

Competitive Comparison of Medical Marijuana's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Marijuana's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Marijuana's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Marijuana's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medical Marijuana's Debt-to-Revenue falls into.

Medical Marijuana Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Medical Marijuana's Debt-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.41	+	13.432)	/	26.523
	=	0.56

Medical Marijuana's annualized Debt-to-Revenue for the quarter that ended in Dec. 2017 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.41	+	13.432)	/	26.523
	=	0.56

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Dec. 2017) Revenue data.

Medical Marijuana Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medical Marijuana's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Marijuana (Medical Marijuana) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Marijuana Inc (OTCPK:MJNA) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

2384 La Mirada Drive, Vista, CA, USA, 92081

Website

https://www.medicalmarijuanainc.com

Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others.